glp-1 agonist benefits Receptor Agonists in Heart Failure Management Frontiers | Exploring the multifaceted

While BW reduction likely contributes to improvements in conditions, such as hepatic steatosis or sleep apnea, GLP-1 RAs may also exert direct disease-specific effects, particularly through central mechanisms implicated in neurodegeneration and addiction [39]

Most importantly, the effects of GLP-1RAs are not consistent 28

These acute anorexigenic and weight-reducing effects of d-allulose were not observed in Glp1r KO mice-fed HFD for 5 weeks or longer (Fig

These recommendations were motivated by the results of a recent cardiovascular outcomes trial (SELECT study), performed in obese subjects without diabetes, which reported a 20% reduction in the composite endpoint of cardiovascular death, non-fatal myocardial infraction and non-fatal stroke

Contamination at this stage introduces bacteria that can multiply in the solution over the coming weeks, ruining the entire vial

therefore, it does not require ethical approval from an Institutional Review Board (IRB) or participant consent